CLINICAL_TRIALS trial_result · 2016-04-26

Clinical Trial Update: Strategies to Improve Islet Survival [Phase 2]

Phase 2 clinical trial update evaluating strategies to improve pancreatic islet survival in Type 1 diabetes; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED